NANO.PA - NANOBIOTIX
€5.70 -0.07 (-1.21%)
Updated: 12:00 May 12, 2024 ESTNext Session's AI Forecast
96.9%
Avg. Accuracy (AI)
€5.5
Next Week's AI Forecast
100%
Trend's Accuracy (AI)
€5.9
| Rank (0-100) |
| Rank (0-100) |
| Curr. Week | Curr. Month | Curr. Quarter | Next Quarter | Curr Year | 1.63 | 1.2 | -0.08 | 0.16 | 0.24 |
|---|
CURRENT VOLATILITY RANK
Variation from the lowest to the highest value in a period.
| Curr. Week | Curr. Month | Curr. Quarter | Next Quarter | Curr Year | 1.95 | 2.36 | 2.01 | 2.16 | 3.21 |
|---|
STOCHASTIC METRIC
The STOCHASTIC METRIC shows when a financial asset has moved into an overbought or oversold position.
| Curr. Week | Next Week | Curr. Month | Curr. Quarter | 100% | 100% | 100% | 81.71% |
|---|
MOVING AVERAGE METRIC
| 5 Sessions | Change 5 Sessions | 20 Sessions | Change 20 Sessions | 50 Sessions | Change 50 Sessions | 200 Sessions | 6.63 | 11.43% | 5.95 | 4.75% | 5.68 | -5.33% | 6 |
|---|
RSI METRIC
| RS Hour | RSI Hour | RS Day | RSI Day | 1 | -1 | 4 | 50 |
|---|
NANOBIOTIX Technical Analysis News
NANOBIOTIX
60 rue de Wattignies
Paris 75012
France
33 1 40 26 04 70
https://www.nanobiotix.com
| Sectors: | Healthcare |
| Industry: | Biotechnology |
| F. Time Employees: | 102 |
Description
Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is headquartered in Paris, France.
Corporate Governance
Nanobiotix S.A.’s ISS Governance QualityScore as of May 1, 2024 is 9. The pillar scores are Audit: 9; Board: 8; Shareholder Rights: 7; Compensation: 10.
List of holders with stock participation in NANOBIOTIX.
| Holder Rank | Holder | Shares | Date Reported | % Out | Value |
|---|